CLINICAL_TRIALS
trial_result
· 2019-07-31
Clinical Trial Update: Vismodegib in Basal Cell Carcinomas (BCC) Chemoprevention [Phase 2]
Summary
Phase 2 trial update for vismodegib in basal cell carcinomas has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Arizona | Conditions: Basal Cell Carcinomas | Phase 2 | Status: TERMINATED | Results posted: 2019-07-31